‘$1bn here we come.’ — Martin Shkreli told Turing board as Daraprim buy got closer
February 03, 2016 at 10:34 AM EST
Documents show how Turing Pharmaceuticals came to hike a drug price by 5,000% and the role one unpopular biotech executive played in that process.
